These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31830614)

  • 1. Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment.
    Badihi A; Frušić-Zlotkin M; Soroka Y; Benhamron S; Tzur T; Nassar T; Benita S
    Nanomedicine; 2020 Feb; 24():102140. PubMed ID: 31830614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
    Puigdemont A; Brazís P; Ordeix L; Dalmau A; Fuertes E; Olivar A; Pérez C; Ravera I
    Vet J; 2013 Aug; 197(2):280-5. PubMed ID: 23562341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis.
    De Rie MA; Meinardi MM; Bos JD
    Acta Derm Venereol; 1991; 71(5):452-4. PubMed ID: 1684481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
    Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim CH; Choi YS; Cheong KA; Lee AY
    Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model.
    Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY
    Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of atopic dermatitis with topical application of Spirodela polyrhiza.
    Lee HJ; Kim MH; Choi YY; Kim EH; Hong J; Kim K; Yang WM
    J Ethnopharmacol; 2016 Mar; 180():12-7. PubMed ID: 26778605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Jung KE; Lee YJ; Ryu YH; Kim JE; Kim HS; Kim BJ; Kang H; Park YM
    Int Immunopharmacol; 2015 Jun; 26(2):432-8. PubMed ID: 25794646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles.
    Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Sahudin S
    Int J Nanomedicine; 2014; 9():5143-56. PubMed ID: 25395851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine-A for severe childhood atopic dermatitis: clinical experience on efficacy and safety profile.
    Sarıcaoğlu H; Yazici S; Zorlu Ö; Bülbül Başkan E; Aydoğan K
    Turk J Med Sci; 2018 Oct; 48(5):933-938. PubMed ID: 30384556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory Effect of Centella asiatica Extract on DNCB-Induced Atopic Dermatitis in HaCaT Cells and BALB/c Mice.
    Lee Y; Choi HK; N'deh KPU; Choi YJ; Fan M; Kim EK; Chung KH; An AJH
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32033291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical skin treatment with Fab fragments of an allergen-specific IgG1 monoclonal antibody suppresses allergen-induced atopic dermatitis-like skin lesions in mice.
    Sae-Wong C; Mizutani N; Kangsanant S; Yoshino S
    Eur J Pharmacol; 2016 May; 779():131-7. PubMed ID: 26970183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of skin inflammation and atopic dermatitis by topical application of a novel ceramide derivative, K112PC-5, in mice.
    Kang JS; Lee CW; Lee K; Han MH; Lee H; Youm JK; Jeong SK; Park BD; Han SB; Han G; Park SK; Kim HM
    Arch Pharm Res; 2008 Aug; 31(8):1004-9. PubMed ID: 18787789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotide.
    Dajee M; Muchamuel T; Schryver B; Oo A; Alleman-Sposeto J; De Vry CG; Prasad S; Ruhrmund D; Shyamsundar R; Mutnick D; Mai K; Le T; Parham C; Zhang J; Komuves L; Colby T; Hudak S; McEvoy LM; Ehrhardt RO
    J Invest Dermatol; 2006 Aug; 126(8):1792-803. PubMed ID: 16628194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone-induced atopic dermatitis in murine model.
    Goindi S; Kumar G; Kaur A
    J Liposome Res; 2014 Sep; 24(3):249-57. PubMed ID: 24646413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice.
    Yang F; Tanaka M; Wataya-Kaneda M; Yang L; Nakamura A; Matsumoto S; Attia M; Murota H; Katayama I
    Exp Dermatol; 2014 Aug; 23(8):568-72. PubMed ID: 24903639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
    Pople PV; Singh KK
    Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory model.
    Frušić-Zlotkin M; Soroka Y; Tivony R; Larush L; Verkhovsky L; Brégégère FM; Neuman R; Magdassi S; Milner Y
    Exp Dermatol; 2012 Dec; 21(12):938-43. PubMed ID: 23171455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.